New Drugs To Watch: Three Winners Matthew Herper, 03.26.04, 5:45 AM ET
NEW YORK - Drugs fail many times before they reach the market--and can rack up many wins before they finally fail. That said, some of the medicines on our watch list recently took small steps closer to patients who desperately need them. The past month has been a relatively slow one for the drugs on our watch list of experimental medicines, but enough encouraging news managed to trickle out for us to declare these three drugs "winners," at least for now.
im not sure whats going on in this tread. But what I see is that forbes page of caner drugs to watch has been changed so that 3 of them now show of in green - but from what I can see provenge is not included. When that is said, the forbes site seems wery weard (seems like its been redesigned)- you have to hit stop in your browser to view the page otherwise you get redirrected, this is an old link and the one posted by jerzee is not working for me.
In my own twisted way, the introduction (posted) is in a way linked to the statement that accompanied the "coverage initiation" blah, blah! Failure/success/failure and the undeniable fact that most Wall Street types have little patience outside the remit of numbers and projections (how much are you producing, what are your margins, is there a demand?).
Medicine (Research) comes from a different angle to which most analysts can only contemplate on a tiptoe, to many uncertainities for them to have a - strong buy or anything along that line, this is science (a .001 difference in statistical significance is not like missing a penny in earnings) , the more ambigous analysts remain the more they protect their credibilty in the future (they aint clairvoyants!)
NEW YORK - The race is on for new medicines to fight cancer. Here is a watch list of the most promising experimental drugs. Click on the drug names in the table below for more information, including sales forecasts and novelty ratings. Bookmark this page as it will be updated often.